James Garegnani

Corporate Officer/Principal presso Gavis Pharmaceuticals LLC

Consumer Services

Health Technology

Profilo

James Garegnani is currently working as the Director-Product Development at Gavis Pharmaceuticals LLC since 2010.
He holds an MBA from Southern Illinois University and an undergraduate degree from Monmouth College.

Posizioni attive di James Garegnani

Società	Posizione	Inizio
Gavis Pharmaceuticals LLC Gavis Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology GAVIS Pharmaceuticals LLC is a marketer, distributor, wholesaler, and business customer specializing in customer service to the pharmaceutical industry. Its products include dexmethylphenidate hydrochloride, dextroamphetamine sulfate, dextroamphetamine sulfate, methylphenidate hydrochloride, misoprostol, nifedipine, nitrofurantoin, nystatin, phenelzine sulfate, and other related products. The company was founded was founded by Veerappan Sellappan Subramanian in July 2008 and is headquartered in Somerset, NJ.	Corporate Officer/Principal	01/08/2010

Tutte le posizioni attive di James Garegnani

Formazione di James Garegnani

Monmouth College	Undergraduate Degree
Southern Illinois University	Masters Business Admin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di James Garegnani

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	1
Gavis Pharmaceuticals LLC Gavis Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology GAVIS Pharmaceuticals LLC is a marketer, distributor, wholesaler, and business customer specializing in customer service to the pharmaceutical industry. Its products include dexmethylphenidate hydrochloride, dextroamphetamine sulfate, dextroamphetamine sulfate, methylphenidate hydrochloride, misoprostol, nifedipine, nitrofurantoin, nystatin, phenelzine sulfate, and other related products. The company was founded was founded by Veerappan Sellappan Subramanian in July 2008 and is headquartered in Somerset, NJ.	Health Technology